Compounds > 3-hydroxyephedrine
Page last updated: 2024-08-22

3-hydroxyephedrine and Chronic Disease

3-hydroxyephedrine has been researched along with Chronic Disease in 2 studies

*Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). [MeSH]

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Beanlands, RSB; Burwash, IG; Chen, SY; DaSilva, JN; deKemp, RA; Dinculescu, V; Kaps, N; Lapierre, C; Lavallee, A; Mielniczuk, LM; Miner, R; Renaud, JM; Thackeray, J; Wang, T; Wu, KY; Zelt, JGE1
Lehikoinen, P; Malminiemi, K; Någren, K; Pietilä, M; Saraste, M; Ukkonen, H; Voipio-Pulkki, LM1

Trials

1 trial(s) available for 3-hydroxyephedrine and Chronic Disease

ArticleYear
Reduced myocardial carbon-11 hydroxyephedrine retention is associated with poor prognosis in chronic heart failure.
    European journal of nuclear medicine, 2001, Volume: 28, Issue:3

    Topics: Aged; Carbon Radioisotopes; Chronic Disease; Echocardiography; Ephedrine; Female; Follow-Up Studies; Heart; Heart Failure; Humans; Male; Middle Aged; Myocardium; Odds Ratio; Prognosis; Radiopharmaceuticals; Survival Analysis; Tomography, Emission-Computed

2001

Other Studies

1 other study(ies) available for 3-hydroxyephedrine and Chronic Disease

ArticleYear
Reliable quantification of myocardial sympathetic innervation and regional denervation using [
    European journal of nuclear medicine and molecular imaging, 2020, Volume: 47, Issue:7

    Topics: Aged; Carbon Radioisotopes; Chronic Disease; Denervation; Ephedrine; Female; Heart; Heart Failure; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Reproducibility of Results; Sympathetic Nervous System

2020